Phase 3, Open-Label Multicenter Study of Sotatercept in Japanese Participants With Pulmonary Arterial Hypertension.

Saved in:
Bibliographic Details
Title: Phase 3, Open-Label Multicenter Study of Sotatercept in Japanese Participants With Pulmonary Arterial Hypertension.
Authors: Matsubara H; NHO Okayama Medical Center, Okayama, Japan., Tanabe N; Pulmonary Hypertension Center, Chibaken Saiseikai Narashino Hospital, Chiba, Japan., Ogo T; Division of Pulmonary Circulation, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan., Abe K; Department of Cardiovascular Medicine Kyushu University Graduate School of Medical Sciences Fukuoka, Japan., Inami T; Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan., Maeda Y; MSD K.K., Tokyo, Japan., Arano I; MSD K.K., Tokyo, Japan. Electronic address: ichiro.arano@merck.com., Shirakawa M; MSD K.K., Tokyo, Japan., Sakai R; MSD K.K., Tokyo, Japan., Cornell AG; Merck & Co, Inc, Rahway, New Jersey, USA.
Corporate Authors: Sotatercept Study 020 Investigators
Source: JACC. Asia [JACC Asia] 2026 Mar; Vol. 6 (3), pp. 297-309. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier on behalf of the American College of Cardiology Foundation Country of Publication: United States NLM ID: 9918452380106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-3747 (Electronic) Linking ISSN: 27723747 NLM ISO Abbreviation: JACC Asia Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2772-3747
DOI:10.1016/j.jacasi.2025.12.009